Avita Medical-Nachfolgethread-AvitaTherapeutics


Seite 1 von 2
Neuester Beitrag: 26.11.21 12:00
Eröffnet am:26.07.20 09:50von: MedicalAnzahl Beiträge:28
Neuester Beitrag:26.11.21 12:00von: MedicalLeser gesamt:7.119
Forum:Hot-Stocks Leser heute:1
Bewertet mit:
1


 
Seite: < 1 | 2 >  

777 Postings, 2354 Tage MedicalAvita Medical-Nachfolgethread-AvitaTherapeutics

 
  
    #1
1
26.07.20 09:50
Starte den Thread einfach mit Links zum alten Thread

https://www.ariva.de/forum/...l-patentrecht-auf-recell-funhale-384509

https://www.ariva.de/forum/...-recell-funhale-384509?page=1#jumppos34


und einem Link zu Avita Therapeuthics ADR -> stockwatch.com > 1 Year Chart

https://www.stockwatch.com/Chart/...me=1&symbol=RCEL&region=U

Quelle: s.oben  
Angehängte Grafik:
rcel-avitatherapeuticsadr-1y-chart-260720.jpg (verkleinert auf 64%) vergrößern
rcel-avitatherapeuticsadr-1y-chart-260720.jpg
2 Postings ausgeblendet.
Seite: < 1 | 2 >  

777 Postings, 2354 Tage Medical.. avita medical HP wird noch gepflegt

 
  
    #4
18.12.20 20:03

777 Postings, 2354 Tage MedicalRepresentative case example

 
  
    #5
18.12.20 20:09

777 Postings, 2354 Tage Medical4cm2 gesunde Haut = 320 cm2 Behandlungsflaeche

 
  
    #6
18.12.20 20:38
Zitat:"...Bei diesem Verfahren wird eine 0,2 bis 0,3 mm dünne 1 cm² bis 4 cm² große Hautschicht (Spalthaut) aus einem gesunden Areal, zum Beispiel hinter dem Ohr, Leiste oder Oberarminnenseite in örtlicher Betäubung entnommen.......Mit einer entnommenen 1 cm² bzw. 4 cm² großen gesunden Hautoberfläche kann eine 80 cm² bzw. 320 cm² große Fläche behandelt werden. Die erste Hautschicht bildet sich innerhalb einer Woche....." ENDE Ziat
Quelle:https://plastische-frankfurt.de/eingriff/frau/...irn-und-augenbrauen/  

10 Postings, 1190 Tage TessehanaLöschung

 
  
    #7
24.12.20 16:12

Moderation
Zeitpunkt: 26.12.20 13:50
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Erotische Inhalte

 

 

2983 Postings, 1189 Tage WinsloaLöschung

 
  
    #8
01.01.21 03:02

Moderation
Zeitpunkt: 01.01.21 10:33
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Erotischer Inhalt

 

 

1649 Postings, 1189 Tage CiencelyaLöschung

 
  
    #9
02.01.21 03:00

Moderation
Zeitpunkt: 02.01.21 10:35
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Erotischer Inhalt

 

 

1794 Postings, 1189 Tage GgiercaLöschung

 
  
    #10
03.01.21 01:41

Moderation
Zeitpunkt: 03.01.21 10:17
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Erotischer Inhalt

 

 

1717 Postings, 1190 Tage RetiselaLöschung

 
  
    #11
05.01.21 00:43

Moderation
Zeitpunkt: 05.01.21 12:10
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer
Kommentar: Regelverstoß

 

 

1937 Postings, 1178 Tage ElezonnaLöschung

 
  
    #12
08.01.21 05:28

Moderation
Zeitpunkt: 08.01.21 08:18
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Erotischer Inhalt

 

 

1177 Postings, 1176 Tage JulleziaLöschung

 
  
    #13
09.01.21 02:05

Moderation
Zeitpunkt: 09.01.21 11:43
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: mehrfach gesperrte Nachfolge-ID

 

 

777 Postings, 2354 Tage Medicalobal revenue is expected to be $5.1 million

 
  
    #14
12.01.21 21:54
Zitat:"....Preliminary Fiscal Second Quarter Estimates

   U.S based RECELL® revenue is expected to be $5.0 million in the second quarter of 2021 ended December 31, 2020, compared to $5.0 million in the previous quarter. U.S based RECELL revenue increased $1.9 million or 62% over the same quarter in the prior year.
   Total global revenue is expected to be $5.1 million in the second quarter of 2021, compared to $5.1 million in the previous quarter. Total global revenue increased $1.8 million in the current quarter or 57% over the same quarter in the prior year.
   The Company had cash of approximately $59.8 million, a decrease of $6.0 million or 9% over the $65.8 million held at the end of the previous quarter....."Ende Zitat

full Source:https://www.stockwatch.com/News/...10112&symbol=RCEL&region=U  

777 Postings, 2354 Tage Medical.. short position vs. up-gap

 
  
    #15
12.01.21 22:00
Current short position
6th January, 2021* 7.73%
    Change          §
1 day 0.13
1 week 0.29
1 month -0.38
Stock information
       ASX   AVH
§
Source:https://www.shortman.com.au/stock?q=avh


Quelle/Chart:https://www.barchart.com/stocks/quotes/RCEL/interactive-chart  
Angehängte Grafik:
avita_therapeutics_rcel_1y-chart-up-gap.jpg (verkleinert auf 43%) vergrößern
avita_therapeutics_rcel_1y-chart-up-gap.jpg

777 Postings, 2354 Tage Medicalresist. @23.22

 
  
    #16
19.01.21 16:00
Support/Resistance
      Type     Value     Conf.§
resist. 28.86 3
resist. 27.20 2
resist. 26.08 4
resist. 24.52 5
resist. 24.05 4
resist. 23.22 7  <    !
supp 21.87 2
supp 21.25 2
supp 20.72 4
supp 19.87 9
supp 17.59 6
Quelle:http://www.stockta.com/cgi-bin/analysis.pl?symb=RCEL

Recent Trades - Last 10 of 98  (19.01.2021 )<16.00 MEZ
Time ET Ex Price Change Volume
  09:35:38         Q     23.70      0.95       100          §
  09:35:38         Q     23.68      0.93       100          §
  09:35:38         Q     23.67      0.92       100          §
  09:35:38         Q     23.67      0.92       400          §
  09:35:38         Q     23.62      0.87       400          §
  09:35:38         Q     23.71      0.96       100          §
  09:35:38         Q     23.71      0.96       100          §
  09:35:38         Q     23.70     0.995        20          §
  09:35:38         Q     23.58     0.875        25          §
  09:35:38         Q     23.68     0.975        25§
Quelle:https://www.stockwatch.com/Quote/Detail?U:RCEL  

777 Postings, 2354 Tage MedicalAvita Medical weiterhin Notierung in D

 
  
    #17
24.01.21 14:43
..... was mich etwas erstaunt hat ,... in Frankfurt und via Tradegate

https://www.ariva.de/avita_medical-aktie/...split=1&clean_bezug=1

wird weiterhin  der Kurse gestellt für "Avita Medical" !

https://www.ariva.de/forum/...l-patentrecht-auf-recell-funhale-384509

sollte dies so bleiben... bislang konnte ich zu einem möglichen delisting nichts finden... wäre dies ggf. eine gute Alternative zu den ADRs... (aber weshalb gibt es Avita Medical und Avita Therapeutics ?)

 

777 Postings, 2354 Tage Medicaloverbought?

 
  
    #18
24.01.21 15:05
Zitat: "-.........VITA Medical, Inc. RCEL has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because RCEL is now in overbought territory with an RSI value of 80.34.....what is RSI?... readings above 70 suggest an asset is overbought, while an RSI below 30 suggests undervalued conditions are present.....Other Factors...
Over the past one month, investors have witnessed 2 earnings estimate revision lower compared to none higher for the current year. The consensus estimate for RCEL’s has also been on a downward trend over the same time period too, as the estimates have fallen 13% over the last two months.....
..this wasn’t enough,.................... AVITA Medical also has a Zacks Rank #5 (Strong Sell) which puts it into unfortunate company among its peers. So, given all of these factors, i...................nvestors may want to consider exiting this stock now before it falls back to Earth. ..." ENDE Zitat
Quelle:https://finance.yahoo.com/news/...rcel-overbought-drop-130101903.html

Resistance/Support vs. Gaps:http://www.stockta.com/cgi-bin/analysis.pl?symb=RCEL  

777 Postings, 2354 Tage MedicalRCEL Announce Fiscal II.Q.2021 Financial Result

 
  
    #19
04.02.21 13:33
Zitat:"....announced today it plans to release its fiscal second quarter 2021 financial results after the market closes onNASDAQ onThursday, February 11, 2021. Inconjunction with such release, the Company plans to host a conference call and webcast on February 11th at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time(being 8.30am on Friday, February 12, 2021 in Sydney)to discuss its financial results and recent highlights..." ENDE Zitat

Quelle:https://cdn-api.markitdigital.com/apiman-gateway/...094df02a206a39ff4

n.b. derzeit können Anteile in der ISIN: US05380C1027 (US-Symbol: RCEL) von mir nicht in mein/e
Wikifolio gekauft werden, da ausschliesslich Kursnotierungen durch L&S via Handelsplatz, für Käufe in Wikifolios möglich sind. Daher habe ich mich nun doch dazu entschlossen,  (siehe #20) für diverse von mir geführte BranchenWikifolio, Anteile in der WKN: A2P8DT - ISIN: AU000000AVH4 - US-Symbol: AVHHL zu erwerben. Ich hoffe das stellt sich im Nachhinein nicht doch als Fehler heraus und die Titel sind auch künftig weiterhin handelbar....  

777 Postings, 2354 Tage MedicalCash was $59.8 million as of December 31, 2020.

 
  
    #20
18.02.21 11:07
Zitat:"Second Quarter Highlights.....   Reported U.S based RECELL® revenue of $5.0 million in the second quarter of 2021 ended December 31, 2020, a 62% increase over the same quarter in the prior year
   Reported total global revenue of $5.1 million in the second quarter of 2021 ended December 31, 2020, a 57% increase over the same quarter in the prior year......    Commercial metrics:
   °  Procedural volumes were 487 in the second quarter of 2021 versus 496 in the prior quarter ended September 30, 2020....    °  Added 7 new accounts in the second quarter 2021 for a total of 93 accounts
   Enrolled nine patients in the pivotal study assessing the use of the RECELL® System to treat stable vitiligo...Second Quarter 2021 Financial Results
Total global revenue was $5.1 million in the second quarter of 2021, compared to $3.3 million for the same quarter last year and flat to the prior quarter ended September 30, 2020....
Gross margin was 84% for the second quarter of 2021, compared with 74% in the same quarter last year, driven largely by the extension of our shelf-life along with lower shipping costs and increased production............Operating expenses were $10.4 million for the second quarter of 2021, compared with $13.4 million in the same quarter last year. ..." ENDE Zitat
Quelle:https://www.stockwatch.com/News/...10211&symbol=RCEL&region=U  

777 Postings, 2354 Tage MedicalApril,2021-Burn Association 53rd AnnualMeeting

 
  
    #21
04.04.21 14:35
Zitat:"...VALENCIA, Calif. and MELBOURNE, Australia, March 30, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, today announced that 15 abstracts highlighting the clinical and cost-savings benefits of the RECELL® Autologous Cell Harvesting Device (RECELL® System) have been accepted at the American Burn Association (ABA) 53rd Annual Meeting. The meeting, which will be held virtually April 7-9, 2021, annually brings together more than 2,000 multi-disciplinary burn care professionals from around the world.........................“This year’s ABA meeting features the highest number of presentations on the clinical and health economic benefits of the RECELL System since its U.S. Food and Drug Administration approval in 2018,” said Dr. Mike Perry, AVITA Medical’s Chief Executive Officer. “The acceptance and adoption of RECELL is reflected in these physician-initiated presentations, representing the collective experience of 20 burn centers......." ENDE Zitat
Quelle/n:
https://ir.avitamedical.com/news-releases/...-presentation-53r-annual
http://ameriburn.org/education/annual-meeting/virtual-content/
https://www.stockwatch.com/News/Item/U-z8206629-U!RCEL-20210330/U/RCEL
 

9 Postings, 1069 Tage AnkeroccaLöschung

 
  
    #22
24.04.21 02:10

Moderation
Zeitpunkt: 25.04.21 02:06
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: -

 

 

9 Postings, 1069 Tage UrsulaywjwaLöschung

 
  
    #23
24.04.21 13:40

Moderation
Zeitpunkt: 26.04.21 11:17
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Spam

 

 

10 Postings, 1069 Tage KarolinwipgaLöschung

 
  
    #24
24.04.21 23:18

Moderation
Zeitpunkt: 26.04.21 10:51
Aktionen: Löschung des Beitrages, Nutzer-Sperre für immer, Beitrag wird nicht mehr angezeigt.
Kommentar: Spam

 

 

777 Postings, 2354 Tage Medicalpenetration rate 73% of total U.S. burn centers

 
  
    #25
31.05.21 07:49
Zitat:"..Third Quarter Highlights...    Reported RECELL® revenue of $8.8 million in the third quarter of 2021, a 126% increase over the same quarter in the prior year......    Commercial metrics:
       Procedural volumes were 492 in the third quarter of 2021, compared with 408 in the same period last year, and 487 in the prior quarter ended December 31, 2020;......        Added 6 new burn center accounts in the third quarter 2021 for a total of 99 accounts, or a penetration rate of 73% of the 136 total U.S. burn centers;.....        Of the approximate 300 total U.S. burn surgeons:
           244 U.S. burn surgeons have been trained and certified with RECELL® through the third quarter of 2021, for a penetration rate of 81%; and........        147 burn surgeons used RECELL® in the third quarter of 2021, for a penetration rate of nearly 50%...." Ende Zitat
Quelle:https://www.stockwatch.com/News/Item/U-z8236148-U!RCEL-20210513/U/RCEL  

777 Postings, 2354 Tage Medicalpreliminary Fourth Quarter 2021 Financial Results

 
  
    #26
16.06.21 13:34
Zitat:"...For the fiscal quarter ending June 30, 2021, AVITA Medical has to date realized total revenue in excess of its fiscal fourth quarter guidance range of $8.2 million to $8.6 million. Based on the strength of both RECELL® commercial revenue and BARDA related revenue, the Company is raising fiscal Q4 guidance to be in the range of $9.5 - $9.7 million, consisting of $6.0 - $6.2 million of RECELL® commercial revenue and $3.5 million of RECELL® revenue associated with BARDA, the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority within the Office of the Assistance Secretary for Preparedness and Response. RECELL® commercial revenue as revised in the guidance reflects a 55% to 60% increase over the prior year period and 30% to 34% increase over the third quarter of 2021. ..." ENDE Zitat
Quelle:https://www.stockwatch.com/News/Item/U-z8255089-U!RCEL-20210615/U/RCEL  

777 Postings, 2354 Tage MedicalFull-Year of Fiscal 2021 Highlights

 
  
    #27
28.08.21 13:17
Zitat:"..AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results....VALENCIA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ....... today reported financial results for its fourth quarter of fiscal year 2021, ended June 30, 2021............Fourth Quarter of Fiscal Year 2021 Highlights................    Total net revenue increased 166% to $10.3 million compared to $3.9 million in the fourth quarter of 2020...................    Total commercial revenue increased 45% to $6.7 million compared to the prior quarter ended March 31, 2021 and exceeded revised revenue guidance of $6.0-6.2 million.............................Gross profit margin of 80% compared to 77% in the fourth quarter of 2020..............    Net loss of $4.7 million, or $0.19 per share compared to a net loss of $12.9 million, or $0.60 per share in the fourth quarter of 2020........................... As of June 30, 2021, the Company had $110.7 million in cash and cash equivalents, and no debt
   FDA approved expanded use of the RECELL® System in combination with meshed autografting for the treatment of all sizes of acute full-thickness thermal burn wounds for both pediatric and adult patients.............Full-Year of Fiscal 2021 Highlights...............    Total net revenue increased 105% to $29.2 million compared to $14.3 million in the prior year......................    Commercial revenues increased 50% compared to the prior year.......    Gross profit margin of 80% compared to 79% in the prior year
   Net loss of $26.6 million, or $1.17 per share compared to a net loss of $42.0 million, or $2.07 per share, in the prior year........" ENDE Zitat
Quelle:https://www.stockwatch.com/News/Item/U-z8315923-U!RCEL-20210826/U/RCEL  

777 Postings, 2354 Tage Medical1.Q 2022 Highlights - no debt ! $60.4M ca$h

 
  
    #28
26.11.21 12:00
Zitat:" financial results for its first fiscal quarter ended September 30, 2021.
First Quarter Fiscal Year 2022 Highlights.....    Total revenue increased 39% to $7.0 million compared to $5.1 million in the first fiscal quarter of 2021....    Gross profit margin improved 3% to 85% compared to the first fiscal quarter of 2021....    Total operating expenses decreased 18% to $12.3 million compared to $14.9 million in the first fiscal quarter of 2021....    Net loss of $5.9 million, or $0.24 per share compared to a net loss of $10.2 million, or $0.48 per share in the first fiscal quarter of 2021....    As of September 30, 2021, the Company had $60.4 million in cash and cash equivalents and $49.5 million in short-term and long-term marketable securities, and no debt....."Ende Zitat
Source:https://www.stockwatch.com/News/Item/U-z8388525-U!RCEL-20211108/U/RCEL

Links:
https://ir.avitamedical.com/
https://www.barchart.com/stocks/quotes/RCEL/interactive-chart
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=RCEL (buy)
https://www2.asx.com.au/markets/company/AVH
https://sec.report/Document/0001193125-21-326416/d249729dex992.htm  

Seite: < 1 | 2 >  
   Antwort einfügen - nach oben